chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Blood fibrinogen normal, COVID-19, Chest X-ray normal, Cough, Diarrhoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/02, Pfizer, dose #1 02/24, Pfizer, dose #2 10/20, Pfizer, dose #3 09/08 pt cc: cough, fever, diarrhea, myalgais, rhinorrhea, nasal congestion, dyspnea exposure: unknown 09/16 SARS-COV-2 Variant Sequencing result: pending 09/16 09/27 COVID swab, result: detected 09/17 CXR impression: No acute disease in the chest. 09/17 FIBRINOGEN: 371 09/17 DDIMER: 0.27 09/27 COVID swab, result: detected 09/30 clinically resolved
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fibrin D dimer, Myalgia, Nasal congestion, Pyrexia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/02, Pfizer, dose #1 02/24, Pfizer, dose #2 10/20, Pfizer, dose #3 09/08 pt cc: cough, fever, diarrhea, myalgais, rhinorrhea, nasal congestion, dyspnea exposure: unknown 09/16 SARS-COV-2 Variant Sequencing result: pending 09/16 09/27 COVID swab, result: detected 09/17 CXR impression: No acute disease in the chest. 09/17 FIBRINOGEN: 371 09/17 DDIMER: 0.27 09/27 COVID swab, result: detected 09/30 clinically resolved
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/02, Pfizer, dose #1 02/24, Pfizer, dose #2 10/20, Pfizer, dose #3 09/08 pt cc: cough, fever, diarrhea, myalgais, rhinorrhea, nasal congestion, dyspnea exposure: unknown 09/16 SARS-COV-2 Variant Sequencing result: pending 09/16 09/27 COVID swab, result: detected 09/17 CXR impression: No acute disease in the chest. 09/17 FIBRINOGEN: 371 09/17 DDIMER: 0.27 09/27 COVID swab, result: detected 09/30 clinically resolved
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Headache, Lung hyperinflation, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/07 Janssen, dose #1 09/08 pt cc: headache exposure: unknown 09/17 COVID swab, result: detected 09/17 pt admit ED cc: headache, sinus congestion dx: covid infection LOS: 1 4day 09/17 CXR impression: lung hyperinflation may be secondary to vigorous inspiratory effort versus air trapping, otherwise, no radiographic evidence of acute cardiopulmonary disease. 09/19 clinically resolved
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Sinus congestion
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/07 Janssen, dose #1 09/08 pt cc: headache exposure: unknown 09/17 COVID swab, result: detected 09/17 pt admit ED cc: headache, sinus congestion dx: covid infection LOS: 1 4day 09/17 CXR impression: lung hyperinflation may be secondary to vigorous inspiratory effort versus air trapping, otherwise, no radiographic evidence of acute cardiopulmonary disease. 09/19 clinically resolved
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Diarrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/23, Pfizer, dose #1 03/16, Pfizer, dose #2 09/10, Pfizer, dose#3 09/15 pt cc: cough, diarrhea, fatigue, headache, loss of taste or smell, rhinorrhea exposure: unknown 09/17 SARS-COV-2 Variant Sequencing result: pending 10/29 COVID swab, result: detected
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/23, Pfizer, dose #1 03/16, Pfizer, dose #2 09/10, Pfizer, dose#3 09/15 pt cc: cough, diarrhea, fatigue, headache, loss of taste or smell, rhinorrhea exposure: unknown 09/17 SARS-COV-2 Variant Sequencing result: pending 10/29 COVID swab, result: detected
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Diarrhoea, Fatigue
Clinical narrative: Narrative: COVID infection following COVID vaccine series 08/12 Janssen, dose #1 09/13 pt cc: chills, cough, diarrhea, fatigue, fever, headache, rhinorrhea, sore throat exposure; unknown 09/17 COVID swab, result: detected
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Oropharyngeal pain, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 08/12 Janssen, dose #1 09/13 pt cc: chills, cough, diarrhea, fatigue, fever, headache, rhinorrhea, sore throat exposure; unknown 09/17 COVID swab, result: detected
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Myalgia, SARS-CoV-2 test
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/05 Janssen, dose #1 09/12 pt cc: cough, diarrhea, myalgias exposure: unknown 09/17 SARS-COV-2 Variant Sequencing result: pending 09/17 COVID swab, result: detected
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/05 Janssen, dose #1 09/12 pt cc: cough, diarrhea, myalgias exposure: unknown 09/17 SARS-COV-2 Variant Sequencing result: pending 09/17 COVID swab, result: detected
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anosmia, COVID-19, Cough, SARS-CoV-2 test positive, Sinus congestion
Clinical narrative: Narrative: Covid infection after Covid vaccine series. 02/12 COVID vaccine dose #1 03/12 COVID vaccine dose #2 09/15: Sinus congestion, cough, loss of smell 09/17: Regeneron
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood bicarbonate normal, Blood fibrinogen increased, Blood gases, Blood pH normal
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/25, Pfizer, dose #1 03/18, Pfizer, dose #2 09/17, Pfizer, dose #3 09/01 pt admit to medicine cc: 3-4 weeks watery diarrhea, SOB, generalized weakness, and nasal congestion dx: COVID PNA los: 8 days 09/01 pt cc: fatigue, dyspnea exposure: unknown 09/01 ABG result: i-pH 7.41, i-PC02 35.1, i-P02 53, i-HCO3 22.2 09/01 FIBRINOGEN 515 09/01 TROPONIN I <0.016 09/01 DDIMER 0.25 09/01 FERRITIN 998.7 09/02 FIBRINOGEN: 528 09/02 DDIMER: 0.43 09/02 ESR 60 09/03 FIBRINOGEN: 414 09/03 DDIMER: 0.53 09/03 ESR 39 09/04 FIBRINOGEN: 359 09/04 DDIMER: 0.66 09/04 ESR 31 09/05 FIBRINOGEN: 308 09/05 DDIMER: 0.96 09/05 ESR 21 09/06 FIBRINOGEN: 258 09/06 DDIMER: 25.90 09/06 ESR 27 09/06 DDIMER 0.69 09/07 FIBRINOGEN: 271 09/07 DDIMER: 0.84 09/07 ESR 23 09/07 procalcitonin <0.05 09/08 FIBRINOGEN: 261 09/08 DDIMER: 0.76 09/08 ESR 18 09/09 ESR 16 09/09 DDIMER 0.69 09/13 clinically resolved 09/17 COVID swab, result: detected 09/17 SARS-COV-2 Variant Sequencing result: pending
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Diarrhoea, Dyspnoea, Fatigue
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/25, Pfizer, dose #1 03/18, Pfizer, dose #2 09/17, Pfizer, dose #3 09/01 pt admit to medicine cc: 3-4 weeks watery diarrhea, SOB, generalized weakness, and nasal congestion dx: COVID PNA los: 8 days 09/01 pt cc: fatigue, dyspnea exposure: unknown 09/01 ABG result: i-pH 7.41, i-PC02 35.1, i-P02 53, i-HCO3 22.2 09/01 FIBRINOGEN 515 09/01 TROPONIN I <0.016 09/01 DDIMER 0.25 09/01 FERRITIN 998.7 09/02 FIBRINOGEN: 528 09/02 DDIMER: 0.43 09/02 ESR 60 09/03 FIBRINOGEN: 414 09/03 DDIMER: 0.53 09/03 ESR 39 09/04 FIBRINOGEN: 359 09/04 DDIMER: 0.66 09/04 ESR 31 09/05 FIBRINOGEN: 308 09/05 DDIMER: 0.96 09/05 ESR 21 09/06 FIBRINOGEN: 258 09/06 DDIMER: 25.90 09/06 ESR 27 09/06 DDIMER 0.69 09/07 FIBRINOGEN: 271 09/07 DDIMER: 0.84 09/07 ESR 23 09/07 procalcitonin <0.05 09/08 FIBRINOGEN: 261 09/08 DDIMER: 0.76 09/08 ESR 18 09/09 ESR 16 09/09 DDIMER 0.69 09/13 clinically resolved 09/17 COVID swab, result: detected 09/17 SARS-COV-2 Variant Sequencing result: pending
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer normal, Nasal congestion, PCO2 normal, PO2 decreased, Procalcitonin normal
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/25, Pfizer, dose #1 03/18, Pfizer, dose #2 09/17, Pfizer, dose #3 09/01 pt admit to medicine cc: 3-4 weeks watery diarrhea, SOB, generalized weakness, and nasal congestion dx: COVID PNA los: 8 days 09/01 pt cc: fatigue, dyspnea exposure: unknown 09/01 ABG result: i-pH 7.41, i-PC02 35.1, i-P02 53, i-HCO3 22.2 09/01 FIBRINOGEN 515 09/01 TROPONIN I <0.016 09/01 DDIMER 0.25 09/01 FERRITIN 998.7 09/02 FIBRINOGEN: 528 09/02 DDIMER: 0.43 09/02 ESR 60 09/03 FIBRINOGEN: 414 09/03 DDIMER: 0.53 09/03 ESR 39 09/04 FIBRINOGEN: 359 09/04 DDIMER: 0.66 09/04 ESR 31 09/05 FIBRINOGEN: 308 09/05 DDIMER: 0.96 09/05 ESR 21 09/06 FIBRINOGEN: 258 09/06 DDIMER: 25.90 09/06 ESR 27 09/06 DDIMER 0.69 09/07 FIBRINOGEN: 271 09/07 DDIMER: 0.84 09/07 ESR 23 09/07 procalcitonin <0.05 09/08 FIBRINOGEN: 261 09/08 DDIMER: 0.76 09/08 ESR 18 09/09 ESR 16 09/09 DDIMER 0.69 09/13 clinically resolved 09/17 COVID swab, result: detected 09/17 SARS-COV-2 Variant Sequencing result: pending
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate increased, SARS-CoV-2 test positive, Serum ferritin increased, Troponin I normal
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/25, Pfizer, dose #1 03/18, Pfizer, dose #2 09/17, Pfizer, dose #3 09/01 pt admit to medicine cc: 3-4 weeks watery diarrhea, SOB, generalized weakness, and nasal congestion dx: COVID PNA los: 8 days 09/01 pt cc: fatigue, dyspnea exposure: unknown 09/01 ABG result: i-pH 7.41, i-PC02 35.1, i-P02 53, i-HCO3 22.2 09/01 FIBRINOGEN 515 09/01 TROPONIN I <0.016 09/01 DDIMER 0.25 09/01 FERRITIN 998.7 09/02 FIBRINOGEN: 528 09/02 DDIMER: 0.43 09/02 ESR 60 09/03 FIBRINOGEN: 414 09/03 DDIMER: 0.53 09/03 ESR 39 09/04 FIBRINOGEN: 359 09/04 DDIMER: 0.66 09/04 ESR 31 09/05 FIBRINOGEN: 308 09/05 DDIMER: 0.96 09/05 ESR 21 09/06 FIBRINOGEN: 258 09/06 DDIMER: 25.90 09/06 ESR 27 09/06 DDIMER 0.69 09/07 FIBRINOGEN: 271 09/07 DDIMER: 0.84 09/07 ESR 23 09/07 procalcitonin <0.05 09/08 FIBRINOGEN: 261 09/08 DDIMER: 0.76 09/08 ESR 18 09/09 ESR 16 09/09 DDIMER 0.69 09/13 clinically resolved 09/17 COVID swab, result: detected 09/17 SARS-COV-2 Variant Sequencing result: pending
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain
Clinical narrative: extreme BA, slight fatigue, soreness at site Narrative:
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Injection site erythema
Clinical narrative: fatigue, flu like symptoms, redness on site Narrative:
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymphadenopathy, Myalgia
Clinical narrative: Headache, Myalgia, faigue, swollen lymph nodes Narrative:
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Feeling cold, Rhinorrhoea
Clinical narrative: fatigue, chills, coughing, runny nose  Narrative:
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nausea, Pain in extremity, Vomiting
Clinical narrative: Dizziness, Headache, NauseaVomiting, sore arm Narrative:
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Headache, Insomnia, Lymphadenopathy, Rash
Clinical narrative: Headache, Rash burnish rash right anterior chest at clavicle. Swollen lymph nodes, insomina
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity
Clinical narrative: Headache Fatigue, Sore arm, BA Narrative:
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chills, Headache
Clinical narrative: Headache back ache, chills Narrative:
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Injection site pain, Pyrexia
Clinical narrative: Fever, back ache, soreness at injection site, fatigue Narrative:
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Headache, Nasal congestion, Vision blurred
Clinical narrative: BlurredVision, Headache, back ache, nasal congestion Narrative:
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Nausea, Pyrexia, Vomiting
Clinical narrative: Fever, NauseaVomiting, backache Narrative:
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Pyrexia
Clinical narrative: Headache, Fever, Diarrhea, Chills, ba Narrative:
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity
Clinical narrative: Headache fatigue, sore arm Narrative:
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Headache Faitigue Narrative:
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pain in extremity, Pyrexia
Clinical narrative: Headache, Fever, chills, ba, sore arm Narrative:
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Somnolence
Clinical narrative: Headache drowsiness, fatigue Narrative:
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient did not present symptoms or adverse reaction. He was given booster doses from Pfizer and was not of age.
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Psoriasis
Clinical narrative: Received the Moderna Covid-19 vaccine. My psoriasis was over 95% clear (no medication taken) up to the time I received the vaccine, it is now on about 25 to 30 percent of my body, mostly on my buttocks and legs. I know of someone else who has psoriasis and her psoriasis got much worse after the vaccine also. I noticed it getting worse after my second dose. Not sure I will be getting the booster, can't afford for it to get worse.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Bacterial test negative, Biopsy skin abnormal, CD30 expression, Erythema, Folliculitis
Clinical narrative: A 61-year-old man developed multiple crusted erythematous papules on face, trunk and extremities starting 2 weeks after receiving the first recombinant zoster vaccine dose (Shingrix) on October12,2020. He received the second vaccine dose on December 15, 2020 and developed increase in number of lesions worsening. Skin biopsy 2/22/21 revealed T-cell lymphoproliferative disorder, clinically consistent with Lymphomatoid Papulosis. Patient required treatment with steroid injections and oral methotrexate for suppression of skin eruption.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Fungal test negative, Lymphomatoid papulosis, Lymphoproliferative disorder, Papule, Skin lesion
Clinical narrative: A 61-year-old man developed multiple crusted erythematous papules on face, trunk and extremities starting 2 weeks after receiving the first recombinant zoster vaccine dose (Shingrix) on October12,2020. He received the second vaccine dose on December 15, 2020 and developed increase in number of lesions worsening. Skin biopsy 2/22/21 revealed T-cell lymphoproliferative disorder, clinically consistent with Lymphomatoid Papulosis. Patient required treatment with steroid injections and oral methotrexate for suppression of skin eruption.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: While giving COVID-19 Moderna vaccines, a total of 11, the first 2 patient's accidentally were given a dose of 0.3mL Epinephrine (pre-filled syringes). According to the anaphylaxis guidance from CDC, there should be at least 3 doses of Epinephrine on hand and available for anaphylactic reactions due to the COVID-19 vaccination. Prior to administration, there was (1) bag of (11) 0.5mL pre-filled Moderna vaccine and (1) bag of (2) doses of 0.3mg/0.3mL Epinephrine, both being properly labeled on the outside of the light-protecting bags. Once being at the administration site, the administrating nurse had accidentally administered the Epinephrine syringes to the first two patients, thus, ending the round of vaccines with 2 extra doses of Moderna vaccine.
Sex: U
Vaccine: FLUX
Symptoms: Circumstance or information capable of leading to medication error, Extra dose administered, Insurance issue, No adverse event, Product administration error
Clinical narrative: On X/XX/21, a patient was referred by the medical unit to come to the pharmacy for a flu vaccine. It was discovered that she had received two flu vaccines: one from RPh XXXXXX XXXXXXXX on XX/XX/20 and one from PRh on XX/XX/21. On XX/XX/20, the patient received 3 different vaccines: flu, TDAP, and HPV 9. The error was discovered when the pharmacy technician tried to bill her current insurance. Upon investigation, it was discovered that the flu shot given on 10/28/2020 was not inputted into system. It was discovered that the flu shots were billed to two different insurances on the pharmacy system. The XX/XX/20 flu shot was billed to one insurance and the X/XX/21 flu shot was billed to another. Patient reports no adverse reactions. Her doctor has been made aware of the error.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Blood pressure decreased, Lip swelling, Mouth swelling, Pharyngeal swelling
Clinical narrative: ANAPHYLACTIC REACTION, SPECIFICALLY SWOLLEN LIPS, SWOLLEN THROAT AND SWOLLEN UPPER PALATE AND ERRATIC BLOOD PRESSURE.; This spontaneous report received from a patient concerned a 62 year old white, female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1808978, and expiry: UNKNOWN) dose was not reported, 1 total administered at left deltoid on 30-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 30-MAR-2021, the patient experienced anaphylactic reaction, specifically swollen lips, swollen throat and swollen upper palate and erratic blood pressure. The patient was not hospitalized, but patient was at primary care physician's office at the time of getting the vaccine, and they treated her with an epi pen for anaphylactic reaction. The patient stated that she never had an anaphylactic reaction before. Treatment medications (dates unspecified) included: epinephrine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from anaphylactic reaction, specifically swollen lips, swollen throat and swollen upper palate and erratic blood pressure after being given the epinephrine within 5 minutes on 30-MAR-2021. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211129992-COVID-19 VACCINE AD26.COV2.S-anaphylactic reaction, specifically swollen lips, swollen throat and swollen upper palate and erratic blood pressure. This event(s) is labeled per RSI and is therefore considered potentially related.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction
Clinical narrative: ANAPHYLACTIC REACTION, SPECIFICALLY SWOLLEN LIPS, SWOLLEN THROAT AND SWOLLEN UPPER PALATE AND ERRATIC BLOOD PRESSURE.; This spontaneous report received from a patient concerned a 62 year old white, female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1808978, and expiry: UNKNOWN) dose was not reported, 1 total administered at left deltoid on 30-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 30-MAR-2021, the patient experienced anaphylactic reaction, specifically swollen lips, swollen throat and swollen upper palate and erratic blood pressure. The patient was not hospitalized, but patient was at primary care physician's office at the time of getting the vaccine, and they treated her with an epi pen for anaphylactic reaction. The patient stated that she never had an anaphylactic reaction before. Treatment medications (dates unspecified) included: epinephrine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from anaphylactic reaction, specifically swollen lips, swollen throat and swollen upper palate and erratic blood pressure after being given the epinephrine within 5 minutes on 30-MAR-2021. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211129992-COVID-19 VACCINE AD26.COV2.S-anaphylactic reaction, specifically swollen lips, swollen throat and swollen upper palate and erratic blood pressure. This event(s) is labeled per RSI and is therefore considered potentially related.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Postictal state, Seizure, Tonic clonic movements
Clinical narrative: Tested Positive for Covid
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Generalised tonic-clonic seizure, Vital signs measurement
Clinical narrative: Tested Positive for Covid
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested Positive for Covid
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Disorientation, Dizziness, Headache, Nausea
Clinical narrative: Headache; fatigue; vertigo; dizziness; spikes in blood pressure; chest pain; accelerated heartbeat; heavy breathing; nausea; tingling and numbness in limbs; tingling and numbness in limbs; This is a spontaneous report from a contactable consumer (patient). A 38-year-old non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Not reported), via an unspecified route of administration, administered on 04Apr2021 (at the age of 38 years old) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation and administered other vaccine (unknown manufacture) on 04Apr2021. Medical history includes thrombocytopenia from unknown date and unknown if ongoing. The patient has allergic to aspirin for unspecified indication from unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 the patient experienced that Headache, fatigue, vertigo, dizziness, spikes in blood pressure, chest pain, accelerated heartbeat, heavy breathing, nausea, tingling and numbness in limbs. The patient visited emergency room and physician office due to events. The patient received treatment for the events with Antihistamine. The reporter reported events as non-serious. The outcome of the events was not resolved.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal pain, Vaccine positive rechallenge, Vertigo
Clinical narrative: Headache; fatigue; vertigo; dizziness; spikes in blood pressure; chest pain; accelerated heartbeat; heavy breathing; nausea; tingling and numbness in limbs; tingling and numbness in limbs; This is a spontaneous report from a contactable consumer (patient). A 38-year-old non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Not reported), via an unspecified route of administration, administered on 04Apr2021 (at the age of 38 years old) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation and administered other vaccine (unknown manufacture) on 04Apr2021. Medical history includes thrombocytopenia from unknown date and unknown if ongoing. The patient has allergic to aspirin for unspecified indication from unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 the patient experienced that Headache, fatigue, vertigo, dizziness, spikes in blood pressure, chest pain, accelerated heartbeat, heavy breathing, nausea, tingling and numbness in limbs. The patient visited emergency room and physician office due to events. The patient received treatment for the events with Antihistamine. The reporter reported events as non-serious. The outcome of the events was not resolved.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Dizziness, Fatigue, Headache, Heart rate increased
Clinical narrative: Headache; fatigue; vertigo; dizziness; spikes in blood pressure; chest pain; accelerated heartbeat; heavy breathing; nausea; tingling and numbness in limbs; tingling and numbness in limbs; This is a spontaneous report from a contactable consumer (patient). A 38-year-old non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Not reported), via an unspecified route of administration, administered on 04Apr2021 (at the age of 38 years old) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation and administered other vaccine (unknown manufacture) on 04Apr2021. Medical history includes thrombocytopenia from unknown date and unknown if ongoing. The patient has allergic to aspirin for unspecified indication from unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 the patient experienced that Headache, fatigue, vertigo, dizziness, spikes in blood pressure, chest pain, accelerated heartbeat, heavy breathing, nausea, tingling and numbness in limbs. The patient visited emergency room and physician office due to events. The patient received treatment for the events with Antihistamine. The reporter reported events as non-serious. The outcome of the events was not resolved.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypertension, Hyperventilation, Hypoaesthesia, Nausea, Paraesthesia
Clinical narrative: Headache; fatigue; vertigo; dizziness; spikes in blood pressure; chest pain; accelerated heartbeat; heavy breathing; nausea; tingling and numbness in limbs; tingling and numbness in limbs; This is a spontaneous report from a contactable consumer (patient). A 38-year-old non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Not reported), via an unspecified route of administration, administered on 04Apr2021 (at the age of 38 years old) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation and administered other vaccine (unknown manufacture) on 04Apr2021. Medical history includes thrombocytopenia from unknown date and unknown if ongoing. The patient has allergic to aspirin for unspecified indication from unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 the patient experienced that Headache, fatigue, vertigo, dizziness, spikes in blood pressure, chest pain, accelerated heartbeat, heavy breathing, nausea, tingling and numbness in limbs. The patient visited emergency room and physician office due to events. The patient received treatment for the events with Antihistamine. The reporter reported events as non-serious. The outcome of the events was not resolved.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vertigo
Clinical narrative: Headache; fatigue; vertigo; dizziness; spikes in blood pressure; chest pain; accelerated heartbeat; heavy breathing; nausea; tingling and numbness in limbs; tingling and numbness in limbs; This is a spontaneous report from a contactable consumer (patient). A 38-year-old non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Not reported), via an unspecified route of administration, administered on 04Apr2021 (at the age of 38 years old) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation and administered other vaccine (unknown manufacture) on 04Apr2021. Medical history includes thrombocytopenia from unknown date and unknown if ongoing. The patient has allergic to aspirin for unspecified indication from unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 the patient experienced that Headache, fatigue, vertigo, dizziness, spikes in blood pressure, chest pain, accelerated heartbeat, heavy breathing, nausea, tingling and numbness in limbs. The patient visited emergency room and physician office due to events. The patient received treatment for the events with Antihistamine. The reporter reported events as non-serious. The outcome of the events was not resolved.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Inappropriate schedule of product administration, Vaccine positive rechallenge
Clinical narrative: swelling in the left axilla (4cmx3cmx14cm); This is a spontaneous report from a contactable physician (patient). This 66-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number: EL1283) via an unspecified route of administration, administered in arm left on 11Jan2021 13:00 as DOSE 1, SINGLE for covid-19 immunisation (at the age of 66 years). Medical history included covid-19 prior vaccination and osteopenia. Concomitant medication received within 2 weeks of vaccination included bisoprolol fumarate (ZEBETA). The most recent COVID-19 vaccine was administered at hospital facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 14Jan2021 12:00, significant swelling in the left axilla (4cmx3cmx14cm) which was improved 50 percent following the first injection 11Jan2021 but had not changed over the past two months. The patient had five physical therapy sessions with no help. This did not appear to be lymphadenopathy or lymphedema as there were no palpable nodes or swelling of the hands or arms. Physical therapy was given as a treatment for adverse event. The outcome of event was not recovered.  No follow-up attempts are needed. No further information was expected.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test, Swelling
Clinical narrative: swelling in the left axilla (4cmx3cmx14cm); This is a spontaneous report from a contactable physician (patient). This 66-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number: EL1283) via an unspecified route of administration, administered in arm left on 11Jan2021 13:00 as DOSE 1, SINGLE for covid-19 immunisation (at the age of 66 years). Medical history included covid-19 prior vaccination and osteopenia. Concomitant medication received within 2 weeks of vaccination included bisoprolol fumarate (ZEBETA). The most recent COVID-19 vaccine was administered at hospital facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 14Jan2021 12:00, significant swelling in the left axilla (4cmx3cmx14cm) which was improved 50 percent following the first injection 11Jan2021 but had not changed over the past two months. The patient had five physical therapy sessions with no help. This did not appear to be lymphadenopathy or lymphedema as there were no palpable nodes or swelling of the hands or arms. Physical therapy was given as a treatment for adverse event. The outcome of event was not recovered.  No follow-up attempts are needed. No further information was expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Four days after my 1st dose I became itchy; Four days after my 1st dose I became broke out in hives on my knees and for arms that lasted about 2 weeks; This is a spontaneous report from a contactable consumer (patient). This is first of two reports. A 61-year-old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number: ER-8732, Expiry date was not reported), via an unspecified route of administration, administered in Arm Left on 14Apr2021 00:30 (Age at vaccination 61-years-old) as dose 1, single for covid-19 immunization. The patient was not pregnant at the time of vaccination. The patient had no medical history. Concomitant medications included levothyroxine (LEVOTHYROXINE), simvastatin (SIMVASTATIN), montelukast (MONTELUKAST), naproxen (NAPROXEN), all taken for an unspecified indication, start and stop date were not reported. Since the vaccination, the patient had not been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 09:00, the patient experienced four days after her 1st dose she became itchy and broke out in hives on my knees and for arms that lasted about 2 weeks. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient received treatment with diphenhydramine hydrochloride (BENADRYL) for the events. The clinical outcome of the events was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Dyspnoea, Ear, nose and throat examination normal, Electrocardiogram normal
Clinical narrative: Severe vasovagal episode with hyperventilation; Severe vasovagal episode with hyperventilation; shortness of breath; dizziness; nausea; headache; intense pain; tingling; tetany in feet and hands; This is a spontaneous report from a contactable consumer patient reported for himself that:  A 31-year-old male patient received bnt162b2 received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, Solution for injection, lot number- ER8736, expiration date unknown), via an unspecified route of administration, administered in right arm on 28Apr2021 16:00 (Age at vaccination- 31-year-old) DOSE 1, SINGLE for COVID-19 immunization. The patient was allergic to gluten, dairy, mango, ibuprofen and lidocaine. Past drug ibuprofen and lidocaine The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Concomitant medications included L-Methylfolate, B complex, vitamin D and Sambucus ext. The patient received other medications within 2 weeks of vaccination. On 28Apr2021 16:00, the patient had experienced severe vasovagal episode with hyperventilation, shortness of breath, dizziness, nausea, headache, and intense pain, tingling, and tetany in feet and hands. Ae resulted in Emergency room/department or urgent care. It was unknown treatment received for the Adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. At the time of reporting, the outcome of the events were unknown. No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Hyperventilation, Nausea, Pain in extremity
Clinical narrative: Severe vasovagal episode with hyperventilation; Severe vasovagal episode with hyperventilation; shortness of breath; dizziness; nausea; headache; intense pain; tingling; tetany in feet and hands; This is a spontaneous report from a contactable consumer patient reported for himself that:  A 31-year-old male patient received bnt162b2 received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, Solution for injection, lot number- ER8736, expiration date unknown), via an unspecified route of administration, administered in right arm on 28Apr2021 16:00 (Age at vaccination- 31-year-old) DOSE 1, SINGLE for COVID-19 immunization. The patient was allergic to gluten, dairy, mango, ibuprofen and lidocaine. Past drug ibuprofen and lidocaine The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Concomitant medications included L-Methylfolate, B complex, vitamin D and Sambucus ext. The patient received other medications within 2 weeks of vaccination. On 28Apr2021 16:00, the patient had experienced severe vasovagal episode with hyperventilation, shortness of breath, dizziness, nausea, headache, and intense pain, tingling, and tetany in feet and hands. Ae resulted in Emergency room/department or urgent care. It was unknown treatment received for the Adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. At the time of reporting, the outcome of the events were unknown. No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Presyncope, Tetany
Clinical narrative: Severe vasovagal episode with hyperventilation; Severe vasovagal episode with hyperventilation; shortness of breath; dizziness; nausea; headache; intense pain; tingling; tetany in feet and hands; This is a spontaneous report from a contactable consumer patient reported for himself that:  A 31-year-old male patient received bnt162b2 received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, Solution for injection, lot number- ER8736, expiration date unknown), via an unspecified route of administration, administered in right arm on 28Apr2021 16:00 (Age at vaccination- 31-year-old) DOSE 1, SINGLE for COVID-19 immunization. The patient was allergic to gluten, dairy, mango, ibuprofen and lidocaine. Past drug ibuprofen and lidocaine The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Concomitant medications included L-Methylfolate, B complex, vitamin D and Sambucus ext. The patient received other medications within 2 weeks of vaccination. On 28Apr2021 16:00, the patient had experienced severe vasovagal episode with hyperventilation, shortness of breath, dizziness, nausea, headache, and intense pain, tingling, and tetany in feet and hands. Ae resulted in Emergency room/department or urgent care. It was unknown treatment received for the Adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. At the time of reporting, the outcome of the events were unknown. No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Headache, Hyperventilation, Nausea
Clinical narrative: Severe vasovagal episode with hyperventilation; Severe vasovagal episode with hyperventilation; shortness of breath; dizziness; nausea; headache; intense pain; tingling; tetany in feet and hands; This is a spontaneous report from a contactable consumer patient reported for himself that:  A 31-year-old male patient received bnt162b2 received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, Solution for injection, lot number- ER8736, expiration date unknown), via an unspecified route of administration, administered in right arm on 28Apr2021 16:00 (Age at vaccination- 31-year-old) DOSE 1, SINGLE for COVID-19 immunization. The patient was allergic to gluten, dairy, mango, ibuprofen and lidocaine. Past drug ibuprofen and lidocaine The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Concomitant medications included L-Methylfolate, B complex, vitamin D and Sambucus ext. The patient received other medications within 2 weeks of vaccination. On 28Apr2021 16:00, the patient had experienced severe vasovagal episode with hyperventilation, shortness of breath, dizziness, nausea, headache, and intense pain, tingling, and tetany in feet and hands. Ae resulted in Emergency room/department or urgent care. It was unknown treatment received for the Adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. At the time of reporting, the outcome of the events were unknown. No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain, Paraesthesia, Presyncope, Tetany
Clinical narrative: Severe vasovagal episode with hyperventilation; Severe vasovagal episode with hyperventilation; shortness of breath; dizziness; nausea; headache; intense pain; tingling; tetany in feet and hands; This is a spontaneous report from a contactable consumer patient reported for himself that:  A 31-year-old male patient received bnt162b2 received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, Solution for injection, lot number- ER8736, expiration date unknown), via an unspecified route of administration, administered in right arm on 28Apr2021 16:00 (Age at vaccination- 31-year-old) DOSE 1, SINGLE for COVID-19 immunization. The patient was allergic to gluten, dairy, mango, ibuprofen and lidocaine. Past drug ibuprofen and lidocaine The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Concomitant medications included L-Methylfolate, B complex, vitamin D and Sambucus ext. The patient received other medications within 2 weeks of vaccination. On 28Apr2021 16:00, the patient had experienced severe vasovagal episode with hyperventilation, shortness of breath, dizziness, nausea, headache, and intense pain, tingling, and tetany in feet and hands. Ae resulted in Emergency room/department or urgent care. It was unknown treatment received for the Adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. At the time of reporting, the outcome of the events were unknown. No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Burning sensation, Oropharyngeal discomfort, Paraesthesia, Swelling
Clinical narrative: Just under 48 hours after the vaccine, I experienced a large swelling on either side of my neck, up and down the neck. I assume it was my lymph nodes. I felt as if someone was pushing my Adam's apple.; She assume it was her lymph nodes swelling; I got a headache; I have had is a sore; In fact she was awake at night (not normal for her); It felt like she had an adrenaline rush; This is a spontaneous report from a contactable consumer (patient). A 59-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 08Apr2021 13:15 (at the age of 59-year-old) (Lot Number: Er8737; Expiration Date: 21Jul2021) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient had no known allergies. No other vaccine in four weeks and no other medications in two weeks. No COVID prior vaccination and not tested for COVID post vaccination. On 10Apr2021 10:00, the patient just under 48 hours after the vaccine, experienced a large swelling on either side of her neck, up and down the neck. She assume it was her lymph nodes swelling. She felt as if someone was pushing her adam's apple, got a headache and she had a sore. Unpleasant and scary as she though it might get worse and she would choke. This lasted most of the day Saturday. She did not feel ill. She was not tired. In fact she was awake at night (not normal for her). It felt like she had an adrenaline rush. No treatment received for the events. On an unspecified date, the patient recovered from all the events.  No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Agitation, Headache, Limb discomfort, Lymphadenopathy, Middle insomnia
Clinical narrative: Just under 48 hours after the vaccine, I experienced a large swelling on either side of my neck, up and down the neck. I assume it was my lymph nodes. I felt as if someone was pushing my Adam's apple.; She assume it was her lymph nodes swelling; I got a headache; I have had is a sore; In fact she was awake at night (not normal for her); It felt like she had an adrenaline rush; This is a spontaneous report from a contactable consumer (patient). A 59-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 08Apr2021 13:15 (at the age of 59-year-old) (Lot Number: Er8737; Expiration Date: 21Jul2021) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient had no known allergies. No other vaccine in four weeks and no other medications in two weeks. No COVID prior vaccination and not tested for COVID post vaccination. On 10Apr2021 10:00, the patient just under 48 hours after the vaccine, experienced a large swelling on either side of her neck, up and down the neck. She assume it was her lymph nodes swelling. She felt as if someone was pushing her adam's apple, got a headache and she had a sore. Unpleasant and scary as she though it might get worse and she would choke. This lasted most of the day Saturday. She did not feel ill. She was not tired. In fact she was awake at night (not normal for her). It felt like she had an adrenaline rush. No treatment received for the events. On an unspecified date, the patient recovered from all the events.  No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling
Clinical narrative: Just under 48 hours after the vaccine, I experienced a large swelling on either side of my neck, up and down the neck. I assume it was my lymph nodes. I felt as if someone was pushing my Adam's apple.; She assume it was her lymph nodes swelling; I got a headache; I have had is a sore; In fact she was awake at night (not normal for her); It felt like she had an adrenaline rush; This is a spontaneous report from a contactable consumer (patient). A 59-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 08Apr2021 13:15 (at the age of 59-year-old) (Lot Number: Er8737; Expiration Date: 21Jul2021) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient had no known allergies. No other vaccine in four weeks and no other medications in two weeks. No COVID prior vaccination and not tested for COVID post vaccination. On 10Apr2021 10:00, the patient just under 48 hours after the vaccine, experienced a large swelling on either side of her neck, up and down the neck. She assume it was her lymph nodes swelling. She felt as if someone was pushing her adam's apple, got a headache and she had a sore. Unpleasant and scary as she though it might get worse and she would choke. This lasted most of the day Saturday. She did not feel ill. She was not tired. In fact she was awake at night (not normal for her). It felt like she had an adrenaline rush. No treatment received for the events. On an unspecified date, the patient recovered from all the events.  No follow-up attempts are possible. No further information is expected.